Comparing Different Annexin A5 Adducts in Rhesus Monkeys
Author Information
Author(s): Paul McQuade, Marie-Jose Belanger, Xiangjun Meng, Ilonka Guenther, Stephen Krause, Dinko Gonzalez Trotter, Chris Reutelingsperger, Eric Hostetler, Michael Klimas, Huseyin Mehmet, Jacquelynn Cook
Primary Institution: Imaging Research, Merck Research Laboratories, West Point, PA, USA
Hypothesis
The study aims to compare the biodistribution of different Annexin A5 adducts to evaluate their potential clinical use.
Conclusion
The study found significant differences in the biodistribution of various Annexin A5 adducts, but these differences do not preclude the clinical use of the site-specific variant.
Supporting Evidence
- All four adducts showed fast blood clearance with kidney being the organ of highest uptake.
- Significant differences in kidney uptake were observed between AxA5-I and AxA5-II.
- AxA5-II showed higher liver and spleen uptake compared to the nonbinding variant AxA5-IINBV.
Takeaway
Researchers looked at how different versions of a protein called Annexin A5 spread in monkeys to see which one works best for finding dying cells.
Methodology
The study involved PET imaging of four different Annexin A5 adducts in healthy adult male rhesus monkeys to assess their biodistribution.
Limitations
The study had a small sample size (n=3), which may limit the generalizability of the findings.
Participant Demographics
Healthy adult male rhesus monkeys, average weight 9.27 kg.
Statistical Information
P-Value
P = .01 for AxA5-I vs AxA5-II kidney uptake at 3h
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website